Skip to content

Investigating the effectiveness of herbal cosmetic products (hair growth stimulating tonic, eyebrow growth stimulating tonic, hair growth stimulating shampoo, damaged hair revitalizing tonic, cream, face mask and soap) on hair growth and skin rejuvenation and introducing new formulations

A comparative study of the effectiveness of herbal hair growth stimulating solution with minoxidil solution in the treatment of hair loss and evaluation of the anti-blemish effect of herbal cream, mask and soap in the treatment of skin blemish

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240402061400N2
Enrollment
420
Registered
2024-06-29
Start date
2024-05-21
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Nonscarring hair loss. Condition 2: skin blemish. Alopecia NOS Other melanin hyperpigmentation

Interventions

Intervention 1: Intervention group in the shampoo group: 15 cc of minoxidil laminin shampoo between two days for 28 days. Intervention 2: Intervention group in the shampoo group: 15 cc of herbal hair

Sponsors

Razi University Vice president of Research and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Signing a written consent to participate in the study Age between 18-70 years In the categories of hair growth stimulating tonic and hair growth stimulating shampoo: patients must face at least one of the problems: hair loss, baldness or low density of hair. In the category of eyebrow growth stimulating tonic: patients must face at least one of the following problems: eyebrow loss and low density of eyebrows. In the category of hair regenerating tonic: patients must face the problem of damaged hair or hair with frizz. In the categories of creams, masks and soaps: patients must have at least one of the following problems: skin spots, wrinkles on the skin, or darkening of the skin.

Exclusion criteria

Exclusion criteria: pregnancy breastfeeding History of using anabolic steroids in the last 6 months History of using minoxidil 2% to 5% in the form of solution or foam or shampoo in the last 6 months History of using finasteride and anti-androgen drugs in the last 6 months History of taking drugs that cause hypertrichosis such as cyclosporine, systemic corticosteroids in the last 6 months Suffering from chronic and acute kidney, liver, heart, vascular and pulmonary diseases

Design outcomes

Primary

MeasureTime frame
Hair density. Timepoint: At the beginning of the study (before the start of the intervention) and 7, 14, 21 and 28 days after the start of the study. Method of measurement: Digital image and view.;Patient satisfaction. Timepoint: 7, 14, 21 and 28 days after the start of the study. Method of measurement: questionnaire.;Hair regrowth based on doctor's opinion. Timepoint: 7, 14, 21 and 28 days after the start of the study. Method of measurement: Digital image and view.;Size and number of skin spots. Timepoint: At the beginning of the study (before the start of the intervention) and 7, 14, 21 and 28 days after the start of the study. Method of measurement: Digital image and view.

Secondary

MeasureTime frame
Hair growthHeadache. Timepoint: At the beginning of the study (before the start of the intervention) and 7, 14, 21 and 28 days after the start of the study. Method of measurement: Ask the patient.;Itching. Timepoint: At the beginning of the study (before the start of the intervention) and 7, 14, 21 and 28 days after the start of the study. Method of measurement: Ask the patient.;Erythema-redness. Timepoint: At the beginning of the study (before the start of the intervention) and 7, 14, 21 and 28 days after the start of the study. Method of measurement: Ask the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasim Batooie

Razi University

nasim.batooie90@gmail.com+98 83 3427 0181

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026